Karyopharm 8K Filing
Karyopharm Therapeutics files 8K with SEC, disclosing changes in executive compensation and shareholder vote results. The filing also includes financial statements and exhibits.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.